Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1-2 prostate cancer at MRI-targeted biopsy: a multicenter analysis.
Claudia V KeschVlad PanteaTimo SoeterikAlessandro MarquisGiulia la BombardaAllesandro MorlaccoFrancesco BarlettaJan Philipp RadtkeChristopher DarrFelix PreisserFabio ZattoniGiancarlo MarraRoderik C N van den BerghBoris HadaschikGiorgio Gandaglianull nullPublished in: World journal of urology (2022)
Upgrading in ISUP ≤ 2 PCa remains prevalent even in men diagnosed in the MRI era. The use of MRI-TB with concomitant SB allows for the accurate identification of ISUP2 PCa and predicts the risk of AO at RP.
Keyphrases
- radical prostatectomy
- prostate cancer
- contrast enhanced
- magnetic resonance imaging
- end stage renal disease
- diffusion weighted imaging
- chronic kidney disease
- ejection fraction
- newly diagnosed
- mycobacterium tuberculosis
- prognostic factors
- magnetic resonance
- computed tomography
- peritoneal dialysis
- cancer therapy
- high resolution
- ultrasound guided
- clinical trial
- drug delivery